BioCurie, a Wilmington biotech startup that develops AI-based software for cell and gene therapy, is joining the inaugural Cure Xchange Challenge: Health AI for Good.
The one-year incubation residency with Cure, a New York City healthcare innovation campus, includes unrestricted seed money from a $1 million funding pool, mentors and access to in-kind resources from partners like NVIDIA and Amazon Web Services.
BioCurie was one of 10 finalists selected in January, after a round of interviews where the Delaware startup pitched its mechanistic AI technology — known as mAI — for cell and gene therapy [CGT] manufacturing.
“Our solution will enable biopharma companies and contract manufacturers to drive down the time, cost, and risk of CGT production, while improving product quality, safety, and commercial viability,” BioCurie CEO, president, and cofounder Irene Rombel said in the Cure Xchange Challenge Solutions Overview.
Rombel said the tech will allow developers and manufacturers “to accurately predict the best production conditions for their cell, gene, and nucleic acid therapy products.”
In addition to BioCurie, four other AI healthcare startups were selected for the program. They are:
- ALLAGI.AI
- Deepecho
- Every Cure
- Oben Health
The cohort will use AI to address some of the biggest challenges in healthcare, including inequitable care, inefficiencies and high healthcare costs. At the same time, they’ll address ethical concerns with AI, from public trust to fairness to privacy, according to Cure CEO Seema Kumar.
“AI-driven tools have the potential to be a game changer in improving human health and solving health inequities that persist in underserved communities,” Kumar said in a statement. “This innovative group of Challenge winners are pioneering the future of healthcare, where AI responsibly empowers us to create and deliver equitable, accessible and transformative care for all.”
Check out this video to get a glimpse of the Cure Campus and learn more about the program.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
3 ways to support our work:- Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
- Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
- Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
